ArticleFrontiers in immunology2026

Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.

Torsten Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.